ArticleResearch in health services & regions2026
The DMP atlas for North Rhine-Westphalia, Germany: results of the disease management programmes on district level.
Article in Research in health services & regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease Management Programmes (DMP) in Germany were initiated to enhance the quality of ambulatory health care for specific chronic diseases. They aim to prevent the progression of the disease and comorbidity as well as to improve quality of life. It is the purpose of this paper to describe the contents of the web-based DMP atlas for North Rhine-Westphalia. The atlas provides a comprehensive overview of the regional DMP results, including outcomes at district level. In 2024, these analyses encompassed data of approximately 1.8 million patients. Quality of care is displayed by quality indicators for type 2 and type 1 diabetes, coronary heart disease, bronchial asthma, chronic obstructive pulmonary disease, breast cancer and osteoporosis. Outcomes are displayed at district level and can be stratified by age, sex, GPs' or specialists' care within the DMPs, the documentation of selected comorbid conditions and DMP participation period. Furthermore, information on comorbidity, health parameters, risk factors and medication are displayed. Again, these can be stratified by age and sex. The DMP atlas allows to identify areas with lower quality of care and subgroups of particularly vulnerable patients. Consequently, it can be seen as a contribution to the further development and specification of DMPs and ambulatory health care in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.